EFRAX
Sources: the KBO register on 22-11-2026; the National Bank, annual accounts to 30-09-2025 filed on 04-03-2026; the Belgian Official Gazette, latest deed of 08-01-2024.
Grounds
the facts the verdict rests on, each with its source- EFRAX made a profit in every financial year since 2017.Annual accounts 2017 to 2025 page 2
- Equity stands at €438,324, or 75.9% of the balance sheet total of €577,651. The solvency of 75.9% is higher than at 78% of the 89 companies filing micro accounts in pharmaceuticals (NACE 21) in 2025.Annual accounts to 30-09-2025 page 2
- Of the €139,327 of debt, €100,000 runs for more than a year.Annual accounts to 30-09-2025, notes page 2
- The last five annual accounts came in on time. The accounts to 30-09-2025 were filed 57 days before the end of the term.National Bank, filing of 04-03-2026 page 5
Representation
The sole manager, , represents EFRAX alone.
Articles of association, Belgian Official Gazette of 25-05-2016, deed 16311158
Ownership
The accounts in the micro format list no shareholders. founded EFRAX by deed of 25-05-2016.
Deed of 25-05-2016
Financial situation
Annual accounts 2021 to 2025, as filed with the National Bank
Gross margin and net resultin euro
Equity and debtsin euro
Cashin euro
| Financial year | 2021 | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Gross margin | €81,168 | €78,426 | €75,607 | €71,110 | €64,423 | |
| Operating result | €79,611 | €76,867 | €73,997 | €69,276 | €63,273 | |
| Net result | €55,443 | €53,654 | €57,599 | €49,356 | €45,359 | |
| Balance sheet at the closing date | ||||||
| Equity | €292,356 | €346,010 | €343,609 | €392,965 | €438,324 | |
| Debts | €233,125 | €210,742 | €187,147 | €163,561 | €139,327 | |
| Debts due after more than one year | €188,351 | €164,791 | €141,231 | €117,671 | €100,000 | |
| Debts due within one year | €44,774 | €45,951 | €45,916 | €45,890 | €39,327 | |
| Cash | €82,969 | €114,637 | €81,995 | €139,996 | €141,984 | |
| Balance sheet total | €525,481 | €556,752 | €530,756 | €556,526 | €577,651 | |
| Ratios | ||||||
| Solvency | 55.6% | 62.1% | 64.7% | 70.6% | 75.9% | |
| Liquidity | 1.98 | 2.63 | 4.38 | 4.97 | 5.08 | |
Source: Annual accounts to 30-09-2025, micro format, filed on 04-03-2026 (2026-00049347); Annual accounts to 30-09-2024, micro format, filed on 04-03-2025 (2025-00045784); Annual accounts 2021 to 2023, filed from 08-03-2022 to 11-03-2024 (2022-07500118, 2023-00041302, 2024-00043497).
Debts fell by €24,234 in 2025.
The annual accounts to 30-09-2025 state no amount of overdue tax or social security (RSZ) debts.
EFRAX states no turnover; the micro format does not require it. The gross margin, what is left after purchases, fell from €71,110 to €64,423.
Board, signature and ownership
Position on 22-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
The sole manager, , represents EFRAX alone.
Articles of association, Belgian Official Gazette of 25-05-2016, deed 16311158
Board
one director in officeOwnership and group
Shareholders
The accounts in the micro format list no shareholders. founded EFRAX by deed of 25-05-2016.
Deed of 25-05-2016
Board changes
appointed as successor director.
Gazette, deed 24311490Holdings
EFRAX has 1 holding (own accounts to 30-09-2025).
| Country | Company | Equity | Result | |
|---|---|---|---|---|
| Belgium 1 | ||||
| BE | 24.96% | €128,686 | result €122,782 | |
Source: List of holdings in its own accounts to 30-09-2025. Every holding stands with its own latest accounts.
Events and comparison
Every event since the founding, newest first
Annual accounts 2025 filed, 57 days before the deadline.
NBB filingAnnual accounts 2024 filed, 57 days before the deadline.
NBB filingAnnual accounts 2023 filed, 50 days before the deadline.
NBB filingHighest result from 2017 to 2025. The net result of €57,599 is the highest of those years.
FinancialAnnual accounts 2022 filed, 47 days before the deadline.
NBB filingAnnual accounts 2021 filed, 53 days before the deadline.
NBB filingAnnual accounts 2020 filed, 59 days before the deadline.
NBB filingEquity above €200,000. With a profit in every financial year since 2017, equity grows to €236,913.
FinancialAnnual accounts 2019 filed, 58 days before the deadline.
NBB filingAnnual accounts 2018 filed, 56 days before the deadline.
NBB filingEquity above €150,000. With a profit in every financial year since 2017, equity grows to €167,966.
FinancialAnnual accounts 2017 filed, 55 days before the deadline.
NBB filingIncorporation. Founding capital of €100,000, 1,200 shares. Founded by . appointed as manager. Published on 25-05-2016.
Gazette, deed 16311158First establishment. Floris Verbraekenlei 2, Brasschaat.
The return on assets of EFRAX, 7.9%, is higher than at 65% of the 84 companies filing micro accounts in pharmaceuticals (NACE 21) in 2025.
Other findings
Peppol
Reachable for e-invoices since 05-12-2025, under 0208:0654897577.
Sanctions lists
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 22-11-2026 | KBO 0654.897.577 |
| National Bank of Belgium | Annual accounts to 30-09-2025, micro format | 04-03-2026 | 2026-00049347 |
| National Bank of Belgium | Annual accounts to 30-09-2024, micro format | 04-03-2025 | 2025-00045784 |
| National Bank of Belgium | Annual accounts 2021 to 2023 | 08-03-2022 to 11-03-2024 | 2022-07500118, 2023-00041302, 2024-00043497 |
| Belgian Official Gazette | Board | 08-01-2024 | deed 24311490 |
| Belgian Official Gazette | Articles of association with the signing rule | 25-05-2016 | deed 16311158 |
| Peppol Directory | Registration for e-invoices | 05-12-2025 | 0208:0654897577 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 19-11-2026 | |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 21-11-2026 | bankruptcy model of 21 November 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 21 November 2026, computed on 21-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
The scores and ratios are Checked's own calculations, not a credit decision.